196 related articles for article (PubMed ID: 32866512)
21. The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer.
Shiota M; Akamatsu S; Narita S; Sumiyoshi T; Fujiwara M; Uchiumi T; Ogawa O; Habuchi T; Eto M
Pharmacogenomics J; 2021 Aug; 21(4):440-445. PubMed ID: 33649516
[TBL] [Abstract][Full Text] [Related]
22. HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies.
Khalaf DJ; Aragón IM; Annala M; Lozano R; Taavitsainen S; Lorente D; Finch DL; Romero-Laorden N; Vergidis J; Cendón Y; Oja C; Pacheco MI; Zulfiqar M; ; Gleave ME; Wyatt AW; Olmos D; Chi KN; Castro E
Ann Oncol; 2020 Sep; 31(9):1186-1197. PubMed ID: 32574722
[TBL] [Abstract][Full Text] [Related]
23. Germline variants and response to systemic therapy in advanced prostate cancer.
Johnson E; Nussenzveig R; Agarwal N; Swami U
Pharmacogenomics; 2020 Jan; 21(1):75-81. PubMed ID: 31849283
[TBL] [Abstract][Full Text] [Related]
24. Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
Flanagan MR; Doody DR; Voutsinas J; Wu Q; Banda K; Sharifi N; Li CI; Gadi VK
Ann Surg Oncol; 2022 Oct; 29(11):7194-7201. PubMed ID: 35776258
[TBL] [Abstract][Full Text] [Related]
25. Through the Looking-Glass: Reevaluating DHEA Metabolism Through HSD3B1 Genetics.
Naelitz BD; Sharifi N
Trends Endocrinol Metab; 2020 Sep; 31(9):680-690. PubMed ID: 32565196
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation in the HSD3B1 gene and recurrent spontaneous abortions.
Ntostis P; Peraki O; Boulgari A; Agiannitopoulos K; Pantos K; Lamnissou K
J Matern Fetal Neonatal Med; 2012 Apr; 25(4):408-10. PubMed ID: 21631238
[TBL] [Abstract][Full Text] [Related]
27. Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer.
Shiota M; Endo S; Tsukahara S; Tanegashima T; Kobayashi S; Matsumoto T; Eto M
Endocr Relat Cancer; 2024 Jul; 31(7):. PubMed ID: 38688318
[TBL] [Abstract][Full Text] [Related]
28. Expression and gene variation studies deny association of human HSD3B1 gene with aldosterone production or blood pressure.
Verwoert GC; Hofland J; Amin N; Mattace-Raso FU; Sijbrands EJ; Hofman A; van den Meiracker AH; Uitterlinden AG; van Duijn CM; de Jong FH; Danser AH
Am J Hypertens; 2015 Jan; 28(1):113-20. PubMed ID: 24951726
[TBL] [Abstract][Full Text] [Related]
29. Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer.
Mostaghel EA; Zhang A; Hernandez S; Marck BT; Zhang X; Tamae D; Biehl HE; Tretiakova M; Bartlett J; Burns J; Dumpit R; Ang L; Matsumoto AM; Penning TM; Balk SP; Morrissey C; Corey E; True LD; Nelson PS
Clin Cancer Res; 2019 Jan; 25(1):426-439. PubMed ID: 30181386
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II triggers expression of the adrenal gland zona glomerulosa-specific 3β-hydroxysteroid dehydrogenase isoenzyme through de novo protein synthesis of the orphan nuclear receptors NGFIB and NURR1.
Ota T; Doi M; Yamazaki F; Yarimizu D; Okada K; Murai I; Hayashi H; Kunisue S; Nakagawa Y; Okamura H
Mol Cell Biol; 2014 Oct; 34(20):3880-94. PubMed ID: 25092869
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer.
Chang YC; Lin CH; Lin JC; Cheng SP; Chen SN; Liu CL
J Surg Res; 2019 Sep; 241():8-14. PubMed ID: 31004874
[TBL] [Abstract][Full Text] [Related]
32. HSD3B1 genotype predicts castration resistance.
Thoma C
Nat Rev Urol; 2020 Apr; 17(4):193. PubMed ID: 32112052
[No Abstract] [Full Text] [Related]
33. Human placental 3β-hydroxysteroid dehydrogenase/steroid Δ5,4-isomerase 1: Identity, regulation and environmental inhibitors.
Zhu Q; Pan P; Chen X; Wang Y; Zhang S; Mo J; Li X; Ge RS
Toxicology; 2019 Sep; 425():152253. PubMed ID: 31351905
[TBL] [Abstract][Full Text] [Related]
34. Two Zebrafish hsd3b Genes Are Distinct in Function, Expression, and Evolution.
Lin JC; Hu S; Ho PH; Hsu HJ; Postlethwait JH; Chung BC
Endocrinology; 2015 Aug; 156(8):2854-62. PubMed ID: 25974401
[TBL] [Abstract][Full Text] [Related]
35. Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.
Chang YC; Chen CK; Chen MJ; Lin JC; Lin CH; Huang WC; Cheng SP; Chen SN; Liu CL
Ann Surg Oncol; 2017 Dec; 24(13):4033-4041. PubMed ID: 28744792
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer.
Shiota M; Fujimoto N; Sekino Y; Tsukahara S; Nagakawa S; Takamatsu D; Abe T; Kinoshita F; Ueda S; Ushijima M; Matsumoto T; Kashiwagi E; Inokuchi J; Uchiumi T; Oda Y; Eto M
Andrologia; 2022 Feb; 54(1):e14307. PubMed ID: 34747051
[TBL] [Abstract][Full Text] [Related]
37. Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer.
Kruse ML; Patel M; McManus J; Chung YM; Li X; Wei W; Bazeley PS; Nakamura F; Hardaway A; Downs E; Chandarlapaty S; Thomas M; Moore HC; Budd GT; Tang WHW; Hazen SL; Bernstein A; Nik-Zainal S; Abraham J; Sharifi N
JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34520399
[TBL] [Abstract][Full Text] [Related]
38. A phosphorylation switch controls androgen biosynthesis in prostate cancer.
Qiu Y
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647834
[TBL] [Abstract][Full Text] [Related]
39. Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk.
Amrousy YM; Haffez H; Abdou DM; Atya HB
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795973
[TBL] [Abstract][Full Text] [Related]
40. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
